Loading...
Thumbnail Image
Publication

Why is insulin and epinephrine more expensive in the United States than in Canada and the U.K?

Journal Title
Readers/Advisors
Ceulemans, Cedric
Journal Title
Term and Year
Fall 2022
Publication Date
2022
Book Title
Publication Volume
Publication Issue
Publication Begin
Publication End
Number of pages
Research Projects
Organizational Units
Journal Issue
Abstract
In the United States insulin and epinephrine injections are known for being more expensive compared to the United Kingdom and Canada. This paper aims to identify the main causes for the price discrepancy. They include higher rate of demand, the differences between healthcare systems, and the differences in pharmaceutical market structure in the U.S. compared to Canada and the U.K. In the U.S. there is a higher rate of individuals who have diabetes and allergies which is likely to increase the demand for insulin and epinephrine. Another factor that leads to the price discrepancy is the difference in healthcare systems in Canada and the U.K. compared to the U.S. Canada and the U.K. markets have institutions that regulate the prices of drugs for pharmaceutical companies unlike in the U.S
Citation
DOI
Description
Accessibility Statement
Purchase College - State University of New York (PC) is committed to ensuring that people with disabilities have an opportunity equal to that of their nondisabled peers to participate in the College's programs, benefits, and services, including those delivered through electronic and information technology. If you encounter an access barrier with a specific item and have a remediation request, please contact lib.ir@purchase.edu.
Embedded videos